Next Article in Journal
Heterologous DNA–Adenovirus Prime–Boost Strategy Expressing Bluetongue Virus VP2 and VP7 Proteins Protects Against Virulent Challenge
Next Article in Special Issue
Current Status and Challenges of Vaccine Development for Seasonal Human Coronaviruses
Previous Article in Journal
Advances in Biotechnology and the Development of Novel Human Vaccines
Previous Article in Special Issue
Safety and Immunogenicity of Single-Dose of Adsorbed Tetanus Vaccine in Adults Aged 18–44 Years: Randomized, Double-Blind, Positive-Controlled Phase I/III Clinical Trial
 
 
Review

Article Versions Notes

Vaccines 2025, 13(9), 990; https://doi.org/10.3390/vaccines13090990
Action Date Notes Link
article xml file uploaded 22 September 2025 15:01 CEST Original file -
article xml uploaded. 22 September 2025 15:01 CEST Update https://www.mdpi.com/2076-393X/13/9/990/xml
article pdf uploaded. 22 September 2025 15:01 CEST Version of Record https://www.mdpi.com/2076-393X/13/9/990/pdf
article html file updated 22 September 2025 15:03 CEST Original file -
article html file updated 28 September 2025 19:48 CEST Update https://www.mdpi.com/2076-393X/13/9/990/html
Back to TopTop